Advertisement

Ebstein’s Anomaly of the Tricuspid Valve

  • Jonathan Kochav
Chapter
Part of the In Clinical Practice book series (ICP)

Abstract

  • Ebstein’s anomaly of the tricuspid valve accounts for less than 1% of all cases of congenital heart disease, occurring in around 0.5 per 10,000 live births. The age at diagnosis can vary widely, from infancy to elder age, based on the wide spectrum of disease severity that exists. This chapter discusses the embryology and anatomy of Ebstein’s anomaly, the structural and electrical defects that are commonly associated with this malformation, and the surgical and electrophysiological management of these patients when they present as adults.

References

  1. 1.
    Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153:807–13.CrossRefGoogle Scholar
  2. 2.
    Attenhofer Jost CH, Connolly HM, Dearani JA, Edwards WD, Danielson GK. Ebstein’s anomaly. Circulation. 2007;115:277–85.CrossRefGoogle Scholar
  3. 3.
    Ebstein W. Uber einen sehr seltenen Fall von Insufficienz der Valvula tricuspidalis, bedingt durch eine angeborene hochgradige Misshildung derselben [in German]. Arch Anat Physiol. 1866;33:238–54.Google Scholar
  4. 4.
    Van Lingen B, Mc GM, Kaye J, et al. Clinical and cardiac catheterization findings compatible with Ebstein’s anomaly of the tricuspid valve: a report of two cases. Am Heart J. 1952;43:77–88.CrossRefGoogle Scholar
  5. 5.
    Hunter SW, Lillehei CW. Ebstein’s malformation of the tricuspid valve; study of a case together with suggestion of a new form of surgical therapy. Dis Chest. 1958;33:297–304.CrossRefGoogle Scholar
  6. 6.
    Danielson GK, Driscoll DJ, Mair DD, Warnes CA, Oliver WC Jr. Operative treatment of Ebstein’s anomaly. J Thorac Cardiovasc Surg. 1992;104:1195–202.PubMedGoogle Scholar
  7. 7.
    Carpentier A, Chauvaud S, Mace L, et al. A new reconstructive operation for Ebstein’s anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96:92–101.PubMedGoogle Scholar
  8. 8.
    Lamers WH, Viragh S, Wessels A, Moorman AF, Anderson RH. Formation of the tricuspid valve in the human heart. Circulation. 1995;91:111–21.CrossRefGoogle Scholar
  9. 9.
    Safi LM, Liberthson RR, Bhatt A. Current management of Ebstein’s anomaly in the adult. Curr Treat Options Cardiovasc Med. 2016;18:56.CrossRefGoogle Scholar
  10. 10.
    Attenhofer Jost CH, Connolly HM, O’Leary PW, Warnes CA, Tajik AJ, Seward JB. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc. 2005;80:361–8.CrossRefGoogle Scholar
  11. 11.
    Khairy P, Marelli AJ. Clinical use of electrocardiography in adults with congenital heart disease. Circulation. 2007;116:2734–46.CrossRefGoogle Scholar
  12. 12.
    Lev M, Liberthson RR, Joseph RH, et al. The pathologic anatomy of Ebstein’s disease. Arch Pathol. 1970;90:334–43.PubMedGoogle Scholar
  13. 13.
    Nora JJ, Nora AH, Toews WH. Letter: lithium, Ebstein’s anomaly, and other congenital heart defects. Lancet. 1974;2:594–5.CrossRefGoogle Scholar
  14. 14.
    McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta-analysis. Lancet. 2012;379:721–8.CrossRefGoogle Scholar
  15. 15.
    Postma AV, van Engelen K, van de Meerakker J, et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet. 2011;4:43–50.CrossRefGoogle Scholar
  16. 16.
    Digilio MC, Bernardini L, Lepri F, et al. Ebstein anomaly: genetic heterogeneity and association with microdeletions 1p36 and 8p23.1. Am J Med Genet A. 2011;155A:2196–202.CrossRefGoogle Scholar
  17. 17.
    Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK, Deanfield JE. Outcome in neonates with Ebstein’s anomaly. J Am Coll Cardiol. 1992;19:1041–6.CrossRefGoogle Scholar
  18. 18.
    Yetman AT, Freedom RM, McCrindle BW. Outcome in cyanotic neonates with Ebstein’s anomaly. Am J Cardiol. 1998;81:749–54.CrossRefGoogle Scholar
  19. 19.
    Wei W, Zhan X, Xue Y, et al. Features of accessory pathways in adult Ebstein’s anomaly. Europace. 2014;16:1619–25.CrossRefGoogle Scholar
  20. 20.
    Oh JK, Holmes DR Jr, Hayes DL, Porter CB, Danielson GK. Cardiac arrhythmias in patients with surgical repair of Ebstein’s anomaly. J Am Coll Cardiol. 1985;6:1351–7.CrossRefGoogle Scholar
  21. 21.
    Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation. 2008;118:e714–833.PubMedGoogle Scholar
  22. 22.
    Shiina A, Seward JB, Edwards WD, Hagler DJ, Tajik AJ. Two-dimensional echocardiographic spectrum of Ebstein’s anomaly: detailed anatomic assessment. J Am Coll Cardiol. 1984;3:356–70.CrossRefGoogle Scholar
  23. 23.
    DeFaria Yeh D, King ME. Congenital heart disease in the adult: what should the adult cardiologist know? Curr Cardiol Rep. 2015;17:25.CrossRefGoogle Scholar
  24. 24.
    Watson H. Natural history of Ebstein’s anomaly of tricuspid valve in childhood and adolescence. An international co-operative study of 505 cases. Br Heart J. 1974;36:417–27.CrossRefGoogle Scholar
  25. 25.
    Kempny A, Dimopoulos K, Uebing A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life—single centre experience and review of published data. Eur Heart J. 2012;33:1386–96.CrossRefGoogle Scholar
  26. 26.
    Augustin N, Schmidt-Habelmann P, Wottke M, Meisner H, Sebening F. Results after surgical repair of Ebstein’s anomaly. Ann Thorac Surg. 1997;63:1650–6.CrossRefGoogle Scholar
  27. 27.
    da Silva JP, Baumgratz JF, da Fonseca L, et al. The cone reconstruction of the tricuspid valve in Ebstein’s anomaly. The operation: early and midterm results. J Thorac Cardiovasc Surg. 2007;133:215–23.CrossRefGoogle Scholar
  28. 28.
    Kiziltan HT, Theodoro DA, Warnes CA, O’Leary PW, Anderson BJ, Danielson GK. Late results of bioprosthetic tricuspid valve replacement in Ebstein’s anomaly. Ann Thorac Surg. 1998;66:1539–45.CrossRefGoogle Scholar
  29. 29.
    Roberts PA, Boudjemline Y, Cheatham JP, et al. Percutaneous tricuspid valve replacement in congenital and acquired heart disease. J Am Coll Cardiol. 2011;58:117–22.CrossRefGoogle Scholar
  30. 30.
    Chauvaud S, Fuzellier JF, Berrebi A, et al. Bi-directional cavopulmonary shunt associated with ventriculo and valvuloplasty in Ebstein’s anomaly: benefits in high risk patients. Eur J Cardiothorac Surg. 1998;13:514–9.CrossRefGoogle Scholar
  31. 31.
    Frankish K, Daly M, Greenslade J, et al. Electrophysiology assessment and radiofrequency ablation of arrhythmias in adult patients with congenital heart defects: the Christchurch experience. N Z Med J. 2014;127:88–96.PubMedGoogle Scholar
  32. 32.
    Obioha-Ngwu O, Milliez P, Richardson A, Pittaro M, Josephson ME. Ventricular tachycardia in Ebstein’s anomaly. Circulation. 2001;104:E92–4.CrossRefGoogle Scholar
  33. 33.
    Jategaonkar SR, Scholtz W, Horstkotte D, Kececioglu D, Haas NA. Interventional closure of atrial septal defects in adult patients with Ebstein’s anomaly. Congenit Heart Dis. 2011;6:374–81.CrossRefGoogle Scholar
  34. 34.
    Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23:1194–8.CrossRefGoogle Scholar
  35. 35.
    Brown ML, Dearani JA, Danielson GK, et al. Functional status after operation for Ebstein anomaly: the Mayo Clinic experience. J Am Coll Cardiol. 2008;52:460–6.CrossRefGoogle Scholar
  36. 36.
    Gaggin HK, Januzzi JL. MGH cardiology board review book. London: Springer; 2014.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jonathan Kochav
    • 1
  1. 1.Massachusetts General HospitalBostonUSA

Personalised recommendations